187 related articles for article (PubMed ID: 20720562)
1. Resveratrol targets transforming growth factor-β2 signaling to block UV-induced tumor progression.
Kim KH; Back JH; Zhu Y; Arbesman J; Athar M; Kopelovich L; Kim AL; Bickers DR
J Invest Dermatol; 2011 Jan; 131(1):195-202. PubMed ID: 20720562
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis.
Back JH; Zhu Y; Calabro A; Queenan C; Kim AS; Arbesman J; Kim AL
Photochem Photobiol; 2012; 88(5):1165-72. PubMed ID: 22272775
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice.
Hao Y; Huang W; Liao M; Zhu Y; Liu H; Hao C; Liu G; Zhang G; Feng H; Ning X; Li H; Li Z
Fitoterapia; 2013 Apr; 86():84-91. PubMed ID: 23428654
[TBL] [Abstract][Full Text] [Related]
4. A possible link between resveratrol and TGF-beta: resveratrol induction of TGF-beta expression and signaling.
Suenaga F; Hatsushika K; Takano S; Ando T; Ohnuma Y; Ogawa H; Nakao A
FEBS Lett; 2008 Mar; 582(5):586-90. PubMed ID: 18242191
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway.
Chen CL; Chen YH; Tai MC; Liang CM; Lu DW; Chen JT
Drug Des Devel Ther; 2017; 11():163-173. PubMed ID: 28138219
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
7. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
[TBL] [Abstract][Full Text] [Related]
8. Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin.
Reagan-Shaw S; Afaq F; Aziz MH; Ahmad N
Oncogene; 2004 Jul; 23(30):5151-60. PubMed ID: 15122319
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation.
Liu L; Rezvani HR; Back JH; Hosseini M; Tang X; Zhu Y; Mahfouf W; Raad H; Ragi G; Athar M; Kim AL; Bickers DR
PLoS One; 2014; 9(5):e97245. PubMed ID: 24824222
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
Aziz MH; Reagan-Shaw S; Wu J; Longley BJ; Ahmad N
FASEB J; 2005 Jul; 19(9):1193-5. PubMed ID: 15837718
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes.
Davies M; Prime SS; Eveson JW; Price N; Ganapathy A; D'Mello A; Paterson IC
Int J Exp Pathol; 2012 Apr; 93(2):148-56. PubMed ID: 22414291
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells.
Cecchinato V; Chiaramonte R; Nizzardo M; Cristofaro B; Basile A; Sherbet GV; Comi P
Biochem Pharmacol; 2007 Dec; 74(11):1568-74. PubMed ID: 17868649
[TBL] [Abstract][Full Text] [Related]
13. Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
Chilampalli C; Guillermo R; Zhang X; Kaushik RS; Young A; Zeman D; Hildreth MB; Fahmy H; Dwivedi C
BMC Cancer; 2011 Oct; 11():456. PubMed ID: 22014088
[TBL] [Abstract][Full Text] [Related]
14. IOP lowering effect of topical trans-resveratrol involves adenosine receptors and TGF-β2 signaling pathways.
Razali N; Agarwal R; Agarwal P; Froemming GRA; Tripathy M; Ismail NM
Eur J Pharmacol; 2018 Nov; 838():1-10. PubMed ID: 30171854
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38/ MAPK signaling pathway.
Zhang X; Liu X; Kang S; Liu C; Hao Y
Cancer Biomark; 2018; 21(4):797-803. PubMed ID: 29286920
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.
Do TV; Kubba LA; Du H; Sturgis CD; Woodruff TK
Mol Cancer Res; 2008 May; 6(5):695-705. PubMed ID: 18505915
[TBL] [Abstract][Full Text] [Related]
17. [Study of apoptosis related factors regulatory mechanism of resveratrol to human skin squamous cell carcinoma A431 xenograft in nude mice].
Hao YQ; Huang WX; Feng HX; Zhang GH; Ning XH; Li HG; Hao CG; Li ZH
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):464-8. PubMed ID: 23660270
[TBL] [Abstract][Full Text] [Related]
18. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.
Tovar-Vidales T; Clark AF; Wordinger RJ
Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
